1 august 2007 (Synta Inc)
90
Structured Review
Synta Inc
1 august 2007
1 August 2007, supplied by Synta Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1+august+2007/1+august+2007/pm24588594-117-45-52
Average 90 stars, based on 1 article reviews
1 August 2007, supplied by Synta Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1+august+2007/1+august+2007/pm24588594-117-45-52
Average 90 stars, based on 1 article reviews
1 august 2007 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Ca(2+) release-activated Ca(2+) channel inhibitors. Article Snippet: 1Axxam Discovery Chemistry, Via Castellino, 111, 80100 Napoli, Italy 2Axxam Discovery Biology, Via Meucci, 3, 20091 Bresso, Milano, Italy *Author for correspondence: paolo.pevarello.pp@axxam.com Ca2+ release-activated Ca2+ (CRAC) channels are becoming important targets for therapeutic intervention in several areas of disease, including immunology, allergy and cancer.. In parallel to the progression towards reliable methods for measuring CRAC currents and their inhibition, patents have been generated by several companies.. In this Patent Review, an ana lysis of the patents in the CRAC channel inhibition filed is presented. |